-
Mashup Score: 2The Value of AlloHCT in Patients With Blast Phase Myeloproliferative Neoplasms (BP-MPN) | ASH Clinical News | American Society of Hematology - 1 year(s) ago
In recent years, survival outcomes have improved in patients with blast phase (BP) transformation of myeloproliferative neoplasms (MPNs) who undergo allogeneic hematopoietic cell transplant (alloHCT). However, a significant proportion of these patients continue to have a poor prognosis, according to research published in the American Journal of Hematology. Researchers, led by Guillermo Ortí, MD,…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Decitabine Yields Similar Survival Despite Superior Responses Versus HU in MP-CMML | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination February 22, 2023 Thomas R. Collins is a medical journalist based in West Palm Beach, Florida. Despite superior response rates, the hypomethylating agent (HMA) decitabine did not produce event-free survival…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Watch to learn about biosensor medical advances, advantages for MPN care, and future developments from biosensor use.
Source: Patient Empowerment NetworkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration - 4 year(s) ago
Patients with MPNs suffer from accelerated accumulation of subretinal drusen and therefore AMD from an earlier age than healthy individuals. We find that the retinal changes are located only between the neuroretina and the choroidal bloodstream. Further, we find that the drusen accumulation is associated with a higher JAK2V617F allele burden and a higher NLR, suggesting that low-grade chronic…
Source: EClinicalMedicineCategories: Latest Headlines, PayerTweet
In patients with blast phase #myeloproliferative #neoplasms who received #alloHCT, three-year OS rates were found to improve over time from 23% in 2005-2010 to 34% in 2015-2019 https://t.co/BgLgpdoJRj